期刊文献+

皮下注射氨磷汀在头颈部癌放、化疗过程中的保护作用 被引量:2

原文传递
导出
摘要 目的:观察皮下注射氨磷汀在头颈部癌放、化疗过程中的保护作用。方法:初治中、晚期头颈部癌患者62例随机分为对照组和观察组各31例。对照组给予3个疗程奥沙利铂+5-氟尿嘧啶+亚叶酸钙化疗,同步进行7周总量为7 000 cGy的放疗。观察组在对照组放、化疗基础上,于每次放疗前给予氨磷汀500 mg皮下注射。评价2组治疗期间血液毒性与非血液毒性反应(黏膜炎、吞咽困难、口干及神经毒性)及近期疗效。结果:观察组非血液毒性反应发生率、2级以上急性口干初发时间、治疗总时间均低于对照组(P<0.05),放疗剂量高于对照组(P<0.05);观察组血液毒性发生率、近期疗效与对照组比较差异无统计学意义(P>0.05),均未因氨磷汀相关不良反应退出治疗。结论:皮下注射氨磷汀可降低头颈部癌放、化疗过程中出现的非血液毒性反应,药物不良反应轻。
出处 《中华实用诊断与治疗杂志》 2010年第9期902-903,共2页 Journal of Chinese Practical Diagnosis and Therapy
  • 相关文献

参考文献7

  • 1Yuhas J M Spellman J M, Culo F. The role of WR-2721 in radiotherapy and/or chemotherapy[J]. Cancer Clin Trials, 1980, 3(3):211 -216.
  • 2Sasse A D, Clark L G, Sasse E C, et al. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta analysis[J]. Int J Radiat Oncol Biol Phys, 2006,64(3) :784-791.
  • 3Anne P R, Machtay M, Rosenthal D I, et al. A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and neck cancer[J]. Int J Radiat Oneol Biol Phys,2007,67 (2) :445-452.
  • 4Therasse P, Arbuck S G, Eisenhauer E A, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada[J]. J Natl Cancer Inst,2000,92(3):205-216.
  • 5Yuhas J M. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-( 3- aminopropylamino)-etbylphosphorothioic acid [J ]. Cancer Res, 1980,40(5) :1519- 1524.
  • 6Buntzel J, Sehuth J, KiJttner K, et al. Radiochemotherapy with amifostine cytoprotection for head and neck cancer[J].Support Care Cancer,1998,6(2) :155- 160.
  • 7Kouvaris J R, Kouloulias V E, Vlahos L J. Amifostine: the first selective-target and broad spectrum radioprotector [J]. Oncologist, 2007,12(6) : 738 -747.

同被引文献31

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部